Hunan Cancer Hospital
Clinical trials sponsored by Hunan Cancer Hospital, explained in plain language.
-
New hope for advanced breast cancer patients: drug combo trial launches
Disease control Not yet recruitingThis early-phase trial is for people with a type of advanced breast cancer (HR-positive, HER2-negative) that has gotten worse despite standard treatments. It tests a new combination of a targeted chemotherapy drug (sacituzumab govitecan) plus hormone therapy. The main goal is to …
Phase: PHASE1 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 09:57 UTC
-
New combo targets hard-to-treat lung cancer with precision
Disease control Not yet recruitingThis study tests whether a drug called firmonertinib, taken as a pill, combined with targeted radiation can help people with a certain type of stage III lung cancer that cannot be removed by surgery. The cancer must have a specific gene change (EGFR uncommon mutation). About 15 a…
Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC